Teknoseed is the leading early stage venture capital company in southern Sweden having made over 30 investments since inception in 1997. Our business concept is based on becoming a partner early on in companies with good potential for development and the aim is simple. We become a partner to increase the value of the company and to eventually enable a successful exit through a trade sale or an initial public offering on a stock exchange.

 

CellaVision helps the health care sector produce efficient blood cell analysis and assure the quality of morphology. For laboratories, this means a reliable shortcut in daily work and confirmed medtech proficiency

http://www.cellavision.com
 
2011-03-14
Airec secures SEK 25 million from Industrifonden and RWE Innogy
2010-10-20
mBlox acquires Mashmobile

TeknoSeed AB | Phone: +46 46 286 87 56